Skip to main content
Log in

Beeinflussung der cardiazolkrampfschwelle durch veränderten 5-hydroxytryptamingehalt des zentralnervensystems

  • Published:
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie Aims and scope Submit manuscript

Summary

1. The seizure threshold of mice was determined by means of timed i.v. infusion of Pentamethylenetetrazol (Metrazol, Cardiazol), after changing the Serotonin content of the brain by pretreatment with Reserpine, which is known to liberate Serotonin, an inhibitor of amineoxydase activity Iproniazid (IPN), and the precursor of Serotonin 5-Hydroxytryptophan (5-HTP).

2. The facilitation of the tonic extensor seizure response by 5 mg/kg Reserpine was prevented by the previous injection of 100 mg/kg IPN; moreover, after this pretreatment a higher average dose of Metrazol was required to produce extensor seizures, as in controls.

3. IPN 100 mg/kg produced no change of the seizure threshold. A small elevation of the threshold for tonic convulsions was observed after treatment with 50 mg/kg 5-HTP. When the animals were pretreated with IPN, the injection of 5-HTP exerted a distinct elevation of the threshold for tonic convulsions. The same threshold elevation followed the injection of 50 mg/kg Dihydroxyphenylalanin (DOPA) after pretreatment with IPN, while DOPA alone was ineffective.

4. When amine-oxydase activity is inhibited by IPN, an increase of spontaneous activity is exerted by 5-HTP, DOPA and Reserpine. This action, produced by excess of liberated amines, is considered to be related with the observed elevation of threshold for tonic seizures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  • Biehler, W.: Allg. Z. Psychiat. 116, 316 (1940).

    Google Scholar 

  • Blaschko, H.: J. Physiol. (Lond.) 101, 337 (1942).

    Google Scholar 

  • Bonnycastle, D. D., N. J. Giarman and M. K. Paasonen: Brit. J. Pharmacol. 12, 228 (1957).

    Google Scholar 

  • Bonnycastle, D. D., M. K. Paasonen and N. J. Giarman: Fed. Proc. 16, 284 (1957).

    Google Scholar 

  • Brodie, B. B., J. S. Olin, R. G. Kuntzman and P. A. Shore: Science 1957, 1293.

  • Brodie, B. B., A. Pletscher and P. A. Shore: J. Pharmacol. exp. Ther. 116, 9 (1956).

    Google Scholar 

  • Brücke, F., W. Kobinger, O. Kraupp u. B. Pillat: Biochem. Z. 328, 56 (1956).

    Google Scholar 

  • Chen, G., and B. Bohner: Fed. Proc. 15, 408 (1956).

    Google Scholar 

  • Chen, G., and B. Bohner: J. Pharmacol. exp. Ther. 119, 559 (1957).

    Google Scholar 

  • Chen, G., B. Bohner and C. R. Ensor: Proc. Soc. exp. Biol. (N. Y.) 87, 334 (1954).

    Google Scholar 

  • Chen, G., and C. R. Ensor: Proc. Soc. exp. Biol. (N. Y.) 87, 602 (1954).

    Google Scholar 

  • Chen, G., C. R. Ensor and B. Bohner: Proc. Soc. exp. Biol. (N. Y.) 86, 507 (1954).

    Google Scholar 

  • Chessin, M., E. R. Kramer and C. Scott: J. Pharmacol. exp. Ther. 119, 453 (1957).

    Google Scholar 

  • Euler, U. S., v., and P. Udden: Experientia (Basel) 7, 465 (1951).

    Google Scholar 

  • Holtz, P., H. Balzer, E. Westermann u. E. Wezler: Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 231, 333 (1957).

    Google Scholar 

  • Holtz, P., K. Credner u. W. Koepp: Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 200, 356 (1942).

    Google Scholar 

  • Holtz, P., R. Heise u. K. Lüdtke: Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 191, 87 (1939).

    Google Scholar 

  • Holtz, P., u. G. Kroneberg: Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 206, 150 (1949).

    Google Scholar 

  • Holzbauer, M. F., and M. Vogt: J. Neurochem. 1, 8 (1956).

    Google Scholar 

  • Jenney, E. H.: Fed. Proc. 13 370 (1954).

    Google Scholar 

  • Nachtsheim, H.: Dtsch. med. Wschr. 1939, 168.

  • Orloff, M. J., H. L. Williams and C. C. Pfeiffer: Proc. Soc. exp. Biol. (N. Y.) 70, 254 (1949).

    Google Scholar 

  • Paasonen, M. K., and M. Vogt: J. Physiol. (Lond.) 131, 617 (1956).

    Google Scholar 

  • Pletscher, A.: Helv. physiol. pharmacol. Acta 14, C76 (1956).

  • Pletscher, A., P. A. Shore and B. B. Brodie: J. Pharmacol. exp. Ther. 116, 46, 84 (1956).

    Google Scholar 

  • Toman, J. E. P., and L. S. Goodman: Res. Publ. Ass. nerv. ment. Dis. 26, 141 (1947)

    Google Scholar 

  • Udenfriend, S., H. Weissbach and D. F. Bogdanski: J. biol. Chem. 224, 803 (1957).

    Google Scholar 

  • Zeller, E. A., J. Barsky, J. R. Fouts, W. F. Kirchheimer and L. S. Van Orden: Experientia (Basel) 8, 349 (1952).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Mit 1 Textabbildung

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobinger, W. Beeinflussung der cardiazolkrampfschwelle durch veränderten 5-hydroxytryptamingehalt des zentralnervensystems. Naunyn - Schmiedebergs Arch 233, 559–566 (1958). https://doi.org/10.1007/BF00245842

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00245842

Navigation